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Background: Asthma is a complex disease resulting from multiple gene–gene and
gene–environment interactions. Study on gene–gene interactions could provide insight
into the pathophysiologic mechanisms of the disease.
Objectives: We investigated the single nucleotide polymorphisms and interactions among
three different loci in three candidate genes (STAT-6 G2964A, STAT-4 T90089C and IFN-g
T874A) in 95 Chinese asthmatic subjects and 95 matched controls to determine the
possible associations with asthma.
Methods: Genotyping of the gene polymorphisms was performed by means of PCR-SSCP
analysis. Genotype–phenotype associations were examined in dominant and recessive
genetic models using logistic regression. The method of multifactor dimensionality
reduction was used to analyze gene–gene interactions.
Results: No statistically significant difference was found in the distribution of the STAT-6
G2964A polymorphisms between asthmatic patients and controls in this case–control study.
The STAT-4 T90089C polymorphisms were significantly associated with asthma in the
dominant model (p ¼ 0.007). As for the IFN-g T874A, the significant associations were
found in both dominant model (p ¼ 0.004) and recessive model (p ¼ 0.006). A significant
gene–gene interaction was found among STAT-6, STAT-4 and IFN-g on the risk of asthma.
In the best 3-locus model, the odds ratio for the high-risk to the low-risk group was 6.9
(95% CI, 3.5–13.7; po0.0001).
Conclusions: Our findings suggest that STAT-4 T90089C and IFN-g T874A polymorphisms
might be the genetic factors for the risk of asthma in the Chinese population. In addition,
the significant interactions among STAT-6 G2964A, STAT-4 T90089C and IFN-g T874A may
increase an individual’s susceptibility and contribute to the pathogenesis of asthma.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
68752286; fax: +86 23 68752287.
m.cn (Y. Li).
ally to this work.
ARTICLE IN PRESS
Y. Li et al.1978Introduction
Asthma is one of the most common respiratory diseases
caused by acute and chronic bronchial inflammation that
result in variable airway obstruction.1,2 The inflammatory
response of asthma is tightly associated with an immune
disorder characterized by IgE production and an imbalance
between T helper cell 1 (Th1) and T helper cell 2 (Th2), both
of which have a strong genetic component.3–5
The signal transducer and activator of transcription 6
(STAT-6) is critical for effects mediated by IL-4, including
induction of Th2 and IgE responses, and antigen-induced
airway inflammation and hyperresponsiveness.6–9 A few
groups have already studied the association between the
polymorphisms in the 30 untranslated region of the STAT-6
gene and asthma.10–13 However, the results of these studies
are not consistent. The signal transducer and activator of
transcription 4 (STAT-4) is known to be essential for
mediating responses of IL-12 in lymphocytes and for
regulating the differentiation of T helper cells.8,14,15 IFN-g,
a representative TH1 cytokine, also plays an important role
in the induction of immune-mediated inflammatory re-
sponses of asthma.16–19 However, thus far, little is known
about the associations of the STAT-4 and IFN-g gene
polymorphisms with asthma.
In this study, we investigated the single nucleotide
polymorphisms of three genes [G2964A in 30 untranslated
region (the exon 23) of STAT-6, T90089C in intron 11 of STAT-
4 and T874A in intron 1 of IFN-g] in asthmatic patients and
controls in a Chinese population to determine the possible
associations between any of these three genes and asthma.
Gene–gene interactions were also examined with recently
developed multifactor dimensionality reduction (MDR) soft-
ware.20–22
Materials and methods
Study population
One hundred and eighty unrelated subjects (95 asthmatic
subjects and 95 healthy controls) from Chongqing in China
were examined. The mean age was 39 years (range: 22–75
years). There were 50 men and 45 women in two groups.
Each asthmatic subject was diagnosed by a specialist
physician. The subjects meeting the following criteria for
asthma were recruited: (1) at least two symptoms consistent
with asthma (cough, wheeze, and shortness of breath); (2) a
variation of X20% in diurnal peak expiratory flow (PEF)
recording (reference to maximal value); (3) an increase of
X15% in PEF or forced expiratory volume of 1 s (FEV1) with a
b2-agonist; (4) plasma total IgE levels were elevated, and
specific IgE was positive. Plasma total IgE levels were
detected by ELISA kit (Biotinge, Beijing, China). Specific IgE
was detected by Allergy Screen test kit (Arlington Scientific,
Utah, USA), which provides a qualitative in vitro assay for
human antibodies of the IgE class to seven different
inhalation allergens. We selected controls who met the
following criteria: (1) healthy subjects matching on age, sex
and residential region with asthmatic subjects; (2) no
history of allergic disease; (3) normal levels of plasma total
IgE and negative for specific IgE. Both patients and controlswere ethnic Chinese Han. Informed consent was obtained
from all subjects.
Molecular methods
Anticoagulated peripheral blood was obtained from all
subjects. DNA was extracted from blood leucocytes.
Genotyping of the gene polymorphisms was performed by
PCR-SSCP analysis. PCR primers were designed to amplify a
fragment containing each variant. Primers for STAT-6
G2964A variant: forward, 50-GGAGCCAATCCACTCCTTCC-30;
and reverse, 50-CAGACTCCTCCTATGCTCCC-30. Primers for
IFN-g T874A variant: forward, 50-gctgttataattatagctgtc-30;
and reverse, 50-TCA ACAAAGCTGATACTCCA-30. Primers for
STAT-4 T90089C variant: forward, 50-TGTGGAAACTTTGTT-
GCTGCTCT-30; and reverse, 50-GCCAAACTTACCAAATGTC-
GAAAT-30.
PCR reactions were performed in a total volume of 50 ml
containing 50 ng of DNA, each dNTP at 125 mmol, 2U of Pfu
DNA polymerase (Promega, Wisconsin, USA), buffer, and
10 pmol of forward and reverse primer. The cycle conditions
were 95 1C for 5min, and then 40 cycles of 95 1C for 30 s,
60 1C (STAT-6) or 58 1C (STAT-4) or 53 1C (IFN-g) for 30 s, and
72 1C for 30 s, with a final extension step of 7min at 72 1C, in
a MyCycler Thermal Cycler (Bio-Rad, California, USA). After
PCR, fragment lengths were determined by agarose gel
eletrophoresis.
The amplified products were fractionated by electrophor-
esis on polyacrylamide gels at 20 1C for 2 h in a Mini-
PROTEAN 3 Cell (Bio-Rad, California, USA). The gels were
visualized by silver staining. Samples from two known
homozygotic individuals and one heterozygotic individual,
as confirmed by sequencing, were included in each reaction.
Statistical analysis
Allele frequencies were estimated using the gene-counting
method. The w2 goodness-of-fit test was used to examine the
Hardy–Weinberg equilibrium. Genotype–phenotype associa-
tions were examined with dominant and recessive genetic
models. Three genotypes were collapsed into two groups
(e.g. STAT-6 G2964A, dominant model: AA+GA versus AA;
recessive model: GG versus GA+AA). The associations were
evaluated using logistic regression. Odds ratios (OR) for the
risk of asthma and their 95% confidence intervals (CI) were
calculated. All p-values are two-tailed. Logistic regression
analysis was also performed to confirm the results from MDR
analyses. A p-value of o0.05 was considered statistically
significant. All above-mentioned calculations were per-
formed with SPSS version 12.0.1 software.
MDR was used to determine the gene–gene interac-
tions.20–22 This method includes a combined cross-valida-
tion/permutation-testing procedure that minimizes false-
positive results.23 For each combination of a pool of genetic
polymorphisms, cross-validation consistency (CVC) and
testing accuracy were calculated. Cross-validation divides
the data into a training set and a testing set. With
10-crossabilityold cross-validation, the data are divided into
10 equal parts, and the model is developed on 9/10 of the
data (training set) and then tested on 1/10 of the remaining
data (testing set). This is repeated for each possible 9/10
ARTICLE IN PRESS
Table 2 Summary of MDR results.
Model Training
accuracy
Testing
accuracy
p-
value
CVCy
STAT-6 and
STAT-4
0.6497 0.5579 0.0547 9/10
STAT-6, STAT-
4 and IFN-g
0.7175 0.5947 0.0107 10/10
1000-fold permutation test.
yCross-validation consistency.
Gene–gene interactions for asthma 1979and 1/10 of the data, and the resulting 10 testing accuracies
are averaged. CVC is a measure of how many times out of 10
divisions of the data that MDR found the same best model.
Permutation testing was performed to assess the probability
of obtaining a testing accuracy as large or larger than
observed in the original data given the null hypothesis of no
association is true. This is carried out by randomizing the
case–control labels 1000 times and repeating the MDR
analysis on each randomized dataset. This process yields
an empirical distribution of testing accuracies under the null
hypothesis that is in turn used to calculate a p-value. The
model was statistically significant when the p-value derived
from the permutation test was 0.05 or less. We used CVC,
testing accuracy and statistical significance to select the
best model. The best model should be significant and have a
maximum CVC and a higher testing accuracy. The specific
high- and low-risk genotypes in the model were also
determined by MDR. The high-risk genotypes for asthma
were defined as if the ratio of the number of patients to
control subjects was equal to or greater than the threshold
of 1.0. Whereas low-risk groups were defined as if the
threshold was lower than 1.0. The MDR analysis was carried
out using version 1.0.0 of the open-source MDR software
package that is freely available (http://www.epistasis.org).
Results
Asthma and individual polymorphisms
The genotypes of all three polymorphisms in three genes
were distributed according to Hardy–Weinberg equilibrium
(p40.05) in the control group. The frequencies of the
genotypes are listed in Table 1. In the same table, the
results of the association analysis using the dominant and
recessive genetic models are given. No statistically sig-
nificant difference was found in the distribution of the STAT-
6 G2964A polymorphisms between asthmatic patients and
controls. However, The STAT-4 T90089C polymorphisms were
significantly associated with asthma in the dominant modelTable 1 Distribution of genotypes in asthmatic patients and co
Polymorphisms Asthmatic patients (n ¼ 95) (%)
STAT-6 G2964A
GG 36.8
GA 37.9
AA 25.3
STAT-4 T90089C
TT 33.7
TC 29.5
CC 36.8
IFN-g T874A
TT 35.8
TA 35.8
AA 28.4
yOR (95% CI) for the risk of asthma were obtained by logistic regress
recessive model.
w2 test.(p ¼ 0.007). As for the IFN-g T874A polymorphisms, the
significant associations were found in both dominant model
(p ¼ 0.004) and recessive model (p ¼ 0.006).
Gene–gene interactions analysis
Table 2 shows the results of CVC, training accuracy and
testing accuracy obtained from MDR analysis of the data.
The 3-locus model was significant and had a maximum CVC
and a higher testing accuracy. This 3-locus model consisted
of the G2964A in STAT-6, T90089C in STAT-4 and T874A in IFN-
g. The combinations of low- and high-risk groups were
classified in this model (Fig. 1). The OR for the high-risk to
the low-risk group was 6.9 (95% CI, 3.5–13.7; po0.0001). A
significant interaction among G2964A in STAT-6, T90089C in
STAT-4 and T874A in IFN-g on the risk of asthma was also
confirmed by logistic regression analysis (p ¼ 0.04).
Discussion
Studies on association between the polymorphisms of the
STAT-6 gene and asthma have recently been reported. Gao
et al.11 found there was a strong association between
G2964A polymorphisms and mild atopic asthma in antrols.
Controls (n ¼ 95) (%) p-value OR (95% CI)y
0.26
40.0 2.067 (0.98–4.37)
44.2 1.18 (0.64–2.19)
15.8
0.05
38.9 1.59 (1.14–2.22)
40.0 1.39 (0.74–2.60)
21.1
0.006
55.8 3.14 (1.45–6.80)
31.6 2.30 (1.28–4.13)
12.6
ion; the top OR is for dominant genetic model and the bottom for
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Figure 1 Distribution of high-risk (dark shading) and low-risk (light shading) combinations associated with asthma in the significant
gene–gene models using MDR analysis. The number of asthmatic patients (left bar in boxes) and matched controls (right bar in boxes)
is shown for each combination. Boxes were labeled as high-risk if the ratio of the number of patients to controls met or exceeded the
threshold of 1.0.
Y. Li et al.1980Japanese population. However, this association was not
replicated in later studies on Japanese populations.12,13
Similar negative associations were found in both a British
population11 and a Caucasian sib-pair study.10 In the present
study, no significant association was found between asthma
and the G2964A polymorphisms in a Chinese population.
Hence, the biologic importance of described polymorphisms
in STAT-6 remains unclear. Apparently both ethnic and
clinical differences in study populations may add to the
complexity of the results.
STAT-4 spans 120 kb on chromosome 2q32.2–q32.3.24 This
region has been linked to atopy susceptibility in previous
genome-wide scans.25 In previous study, Pyka¨la¨inen et al.26
found no associations of STAT-4 T90089C polymorphisms with
asthma in a Finnish population. However, our study demon-
strated that the STAT-4 T90089C polymorphisms were
associated with asthma in the dominant genetic model.
Our results might be partly confirmed by the recent study of
Park et al.,27 which showed a significant association of STAT-
4 T90089C with the increased production of specific IgE in
Korea asthmatic patients.
We firstly conducted a case–control study to investigate
the association of the IFN-g T874A polymorphisms with
asthma and found that these polymorphisms were signifi-
cantly associated with asthma in both dominant and
recessive model. It has been reported that IFN-g production
was genetically controlled. IFN-g T874A polymorphisms have
been considered directly influencing the level of IFN-g
production.28 The genotypes AA, TA and TTof IFN-g 874 locus
were thought to confer three different phenotypes: low,
intermediate and high producers of IFN-g, respectively.29,30
Therefore, by regulating the level of IFN-g production, IFN-g
T874A polymorphisms may play an important role in
pathophysiologic mechanisms and be a useful marker of
asthma phenotypes.
As for a multifactorial disease, it is clear that asthma is
not caused by a single genetic risk factor. Gene–gene
interactions could provide insight into the pathophysiologicmechanisms of this disease. Traditionally, the identification
and characterization of gene–gene interactions have been
limited by the lack of powerful statistical methods and large
sample size.31 MDR method, overcoming some of the
limitations, is a promising new approach for detecting and
characterizing gene-to-gene interactions in case–control
studies.22 Therefore, the gene–gene interactions were
analyzed with MDR in this study. Our results suggest that
the susceptibility to asthma in the Chinese population
involves gene–gene interactions among STAT-6, STAT-4 and
IFN-g. This result was confirmed by traditional logistic
regression analysis. The immune disorders characterized
by an imbalance between Th1 and Th2 play a central role on
the inflammatory response in asthma.3 The coexistence of
these polymorphisms probably interacts to regulate Th1/Th2
differentiation. It is therefore possible that different
polymorphisms in STAT-6, STAT-4 and IFN-g contribute to
the complex regulation of asthma phenotypes.
In summary, our findings suggest that STAT-4 T90089C and
IFN-g T874A polymorphisms might be the genetic factors for
the risk of asthma in the Chinese population. In addition, the
significant interactions among STAT-6 G2964A, STAT-4
T90089C and IFN-g T874A may increase an individual’s
susceptibility. A limitation of our study is the relatively
small sample size. The contributory role of genetic variants
of STAT-6, STAT-4 and IFN-g genes in asthma is in our opinion
still open to debate. Additional genetic and epidemiological
studies as well as functional analysis are required to fully
elucidate the role of these interesting gene polymorphisms
in the development of asthma.Acknowledgments
This work was supported by a Grant from the Science
Foundation of Third Military Medical University
(#XG200353). We thank Dr. Zhang Li for her technical
assistance of PCR-SSCP.
ARTICLE IN PRESS
Gene–gene interactions for asthma 1981References
1. Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial
hyperreactivity. Am Rev Respir Dis 1980;121:389–413.
2. Cookson W. The alliance of genes and environment in asthma
and allergy. Nature 1999;402:B5–B11.
3. Wills-Karp M. Immunologic basis of antigen-induced airway
hyperresponsiveness. Annu Rev Immunol 1999;17:255–81.
4. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic suscept-
ibility to asthma-bronchial hyperresponsiveness coinherited
with a major gene for atopy. N Engl J Med 1995;333:894–900.
5. Xu J, Postma DS, Howard TD, et al. Major genes regulating total
serum immunoglobulin E levels in families with asthma. Am J
Hum Genet 2000;67:1163–73.
6. Takeda K, Tanaka T, Shi W, et al. Essential role of Stat6 in IL-4
signalling. Nature 1996;380:627–30.
7. Takeda K, Kishimoto T, Akira S. STAT6: its role in interleukin
4-mediated biological functions. J Mol Med 1997;75:317–26.
8. Pernis AB, Rothman PB. JAK-STAT signaling in asthma. J Clin
Invest 2002;109:1279–83.
9. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central
mediator of allergic asthma. Science 1998;282:2258–61.
10. Duetsch G, Illig T, Loesgen S, et al. STAT6 as an asthma
candidate gene: polymorphism-screening, association and
haplotype analysis in a Caucasian sib-pair study. Hum Mol
Genet 2002;11:613–21.
11. Gao PS, Mao XQ, Roberts MH, et al. Variants of STAT6 (signal
transducer and activator of transcription 6) in atopic asthma.
J Med Genet 2000;37:3280–2.
12. Tamura K, Arakawa H, Suzuki M, et al. Novel dinucleotide
repeat polymorphism in the first exon of the STAT-6 gene is
associated with allergic diseases. Clin Exp Allergy 2001;31:
1509–14.
13. Shao C, Suzuki Y, Kamada F, et al. Linkage and association of
childhood asthma with the chromosome 12 genes. J Hum Genet
2004;49:115–22.
14. Kaplan MH, Sun YL, Hoey T, et al. Impaired IL-12 responses and
enhanced development of Th2 cells in Stat4-deficient mice.
Nature 1996;382:174–7.
15. Murphy KM, Ouyang W, Farrar JD, et al. Signaling and
transcription in T helper development. Annu Rev Immunol
2000;18:451–94.
16. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of
murine helper T cell clone. I. Definition according to profiles of
lymphokine activities and secreted proteins. J Immunol 1986;
136:2348–57.
17. Coffman RL, Catty J. A T cell activity that enhances polyclonal
IgE production and its inhibition by interferon-gamma.
J Immunol 1986;136:949–54.18. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased
interferon gamma and increased interleukin-4 production in
atopic dermatitis promotes IgE synthesis. J Allergy Clin
Immunol 1992;90:323–31.
19. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma
production in children with atopic disease. Clin Exp Immunol
1993;92:120–4.
20. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality
reduction software for detecting gene–gene and gene–environ-
ment interactions. Bioinformatics 2003;19:376–82.
21. Ritchie MD, Hahn LW, Moore JH. Power of multifactor
dimensionality reduction for detecting gene–gene interactions
in the presence of genotyping error, missing data, phenocopy,
and genetic heterogeneity. Genet Epidemiol 2003;24:150–7.
22. Moore JH. Computational analysis of gene–gene interactions
using multifactor dimensionality reduction. Expert Rev Mol
Diagn 2004;4:795–803.
23. Coffey CS, Hebert PR, Krumholz HM, Morgan TM, Williams SM,
Moore JH. Reporting of model validation procedures in human
studies of genetic interactions. Nutrition 2004;20:69–73.
24. Yamamoto K, Kobayashi H, Arai A, Miura O, Hirosawa S, Miyasaka
N. cDNA cloning, expression and chromosome mapping of the
human STAT4 gene: both STAT4 and STAT1 genes are mapped to
2q32.2–4q32.3. Cytogenet Cell Genet 1997;77:207–10.
25. Wjst M, Fischer G, Immervoll T, et al. A genome-wide search for
linkage to asthma. German Asthma Genetics Group. Genomics
1999;58:1–8.
26. Pyka¨la¨inen M, Kinos R, Valkonen S, et al. Association analysis of
common variants of STAT6, GATA3, and STAT4 to asthma and
high serum IgE phenotypes. J Allergy Clin Immunol 2005;115:
80–7.
27. Park BL, Cheong HS, Kim LH, et al. Association analysis of signal
transducer and activator of transcription 4 (STAT4) polymorph-
isms with asthma. J Hum Genet 2005;50:133–8.
28. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single
nucleotide polymorphism in the first intron of the human IFN-
gamma gene: absolute correlation with a polymorphic CA
microsatellite marker of high IFN-gamma production. Hum.
Immunol 2000;61:863–6.
29. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for
polymorphisms in interferon-gamma, interleukin-10, transform-
ing growth factor-beta 1 and tumour necrosis factor-alpha
genes: a technical report. Transplant Immunol 1998;6:193–7.
30. Tambur AR, Ortegel JW, Ben-Ari Z, et al. Role of cytokine gene
polymorphism in hepatitis C recurrence and allograft rejection
among liver transplant recipients. Transplantation 2001;71:
1475–80.
31. Moore JH, Williams SM. New strategies for identifying gene–
gene interactions in hypertension. Ann Med 2002;34:88–95.
